The U.S. Food and Drug Administration on Friday approved labeling changes for Johnson & Johnson and its partner Legend Biotech's blood cancer therapy to include a boxed warning for a potentially fatal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback